Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does renal function impact tigecycline's liver safety?How many years does kadcyla's market exclusivity last?How does lipitor's effectiveness differ for arthritis pain?Dabrafenib patent expiration date novartis gsk composition matter?Drugpatentwatch crizotinib?
See the DrugPatentWatch profile for miralax
MiraLAX is the brand name for the laxative polyethylene glycol 3350 (PEG 3350). The product was developed and introduced by Bayer as part of its over-the-counter medicines portfolio. [1]
MiraLAX is associated with Bayer for its U.S. brand history, and Bayer has marketed the product under that name. [1]
Today, MiraLAX remains a Bayer brand in many markets, but specific ownership and marketing rights can vary by country and distribution agreements. [1]
The active ingredient, polyethylene glycol 3350, is a well-known compound in pharmaceuticals and consumer products; MiraLAX is a specific branded formulation of that ingredient. [1] Sources: [1] https://www.bayer.com/en/products-and-innovation/prescription-and-otc-medicines/miralax/
Other Questions About Miralax :